Related Experiment Videos
Compound 48-80. Structure-activity relations and poly-THIQ, a new, more potent analog
Journal of Medicinal Chemistry
|November 1, 1973
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Antagonism of the final common pathway of mast cell histamine secretion by arylalkylamines.
The Journal of pharmacology and experimental therapeutics·1986
Antimicrobial action of compound 48/80--II mechanism of action.
Biochemical pharmacology·1983
Competitive inhibition of 48/80-induced histamine release by benzalkonium chloride and its analogs and the polyamine receptor in mast cells.
The Journal of pharmacology and experimental therapeutics·1982
Benzalkonium chloride: selective inhibitor of histamine release induced by compound 48/80 and other polyamines.
The Journal of pharmacology and experimental therapeutics·1979
Antimicrobial action of compound 48/80 against protozoa, bacteria, and fungi.
Journal of pharmaceutical sciences·1977
Relationship between phosphatidylserine and cromolyn in histamine release.
European journal of pharmacology·1977
Discovery and Optimization of Novel Nonhydroxamate LpxC Inhibitors for the Treatment of Multidrug-Resistant Gram-Negative Infections.
Journal of medicinal chemistry·2026
Fragment-Based Discovery of Potent RNA-Competitive Inhibitors of the DEAH-Box RNA Helicase DHX8.
Journal of medicinal chemistry·2026
Discovery and Optimization of a WRN Helicase Inhibitor Series through Structure-Guided Drug Design from a Covalent Fragment Binding Insight.
Journal of medicinal chemistry·2026
Recent Advances in Antiviral Medicinal Chemistry against Flaviviruses Driven by Multistrategic Approaches.
Journal of medicinal chemistry·2026
In silico and In vitro studies of EGFR kinase and Anilide derivatives as inhibitors against Breast Cancer.
Biotechnology notes (Amsterdam, Netherlands)·2026
Comparative metabolomic and protective effects of Quercus leucotrichophora leaf and acorn extracts against doxorubicin-induced oxidative and inflammatory injury.
Journal of diabetes and metabolic disorders·2026